Clinical trial
"Oral Chronic Graft-Versus-Host Disease (cGVHD) as a Potential Clinical Marker of the Graft-Versus-Leukemia (GVL) Effect in Allogeneic Hematopoietic Stem Cell Transplantation:Prospective Single-Center Study"
NCT07271498 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "Oral Chronic Graft-Versus-Host Disease (cGVHD) as a Potential Clinical Marker of the Graft-Versus-Leukemia (GVL) Effect in Allogeneic Hematopoietic Stem Cell Transplantation:Prospective Single-Center Study"
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2023
- Completion date
- October 1, 2025
- Enrollment
- 93 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allografts, oral cgvhd